The clinical benefits of recombinant gonadotrophins

Comment

E R Hernandez. Hum Reprod. 2000 Mar.

. 2000 Mar;15(3):734-5.

doi: 10.1093/humrep/15.3.734.

No abstract available

Comment on

Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory follicles.
Mason HD, Mannaerts B, de Leeuw R, Willis DS, Franks S. Mason HD, et al. Hum Reprod. 1993 Nov;8(11):1823-7. doi: 10.1093/oxfordjournals.humrep.a137941. Hum Reprod. 1993. PMID: 8288744
What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.
Out HJ, Bennink HJ, de Laat WN. Out HJ, et al. Hum Reprod. 1999 Sep;14(9):2189-90. doi: 10.1093/humrep/14.9.2189. Hum Reprod. 1999. PMID: 10469679 Review. No abstract available.
A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation.
Hoomans EH, Andersen AN, Loft A, Leerentveld RA, van Kamp AA, Zech H. Hoomans EH, et al. Hum Reprod. 1999 Oct;14(10):2442-7. doi: 10.1093/humrep/14.10.2442. Hum Reprod. 1999. PMID: 10527965 Clinical Trial.